建立瘦体重与握力切点同活动障碍及其他健康结局的关联:肌少症定义与结局联盟会议纪要
肌少症定义与结局联盟(SDOC)召开会议,讨论基于证据的肌少症诊断切点。SDOC汇总8个队列18831名参与者、10项随机试验与观察性研究的临床人群及2个全国代表性队列。初步评估显示握力或握力除以体重指数可区分活动障碍(步速<0.8 m/s)风险,而双能X线吸收法测得的瘦体重指标区分能力不佳。基于握力的候选定义与死亡、跌倒、活动障碍及工具性日常生活活动障碍风险增加相关。低握力患病率随年龄增长而升高。
要点
- 握力或握力除以体重指数可区分活动障碍风险,瘦体重指标区分能力不佳。
- 基于握力的候选定义与死亡、跌倒、活动障碍及工具性日常生活活动障碍风险增加相关。
- 低握力患病率随年龄增长而升高,需国际共识建立循证肌少症定义。
核心结论
- 握力绝对值或经体重指数调整的握力是活动障碍及其他终点的重要区分指标,瘦体重指标区分能力不佳,肌少症循证定义亟需国际共识。
研究设计与样本
- SDOC会议通过报告与小组讨论评估肌少症作为生物标志物的效用、SDOC建立切点的分析方法及初步发现。
- SDOC汇总8个流行病学队列共18831名参与者、10项随机试验与观察性研究的临床人群及2个全国代表性队列的数据。
主要发现
- 握力或握力除以体重指数被确定为活动障碍(步速<0.8 m/s)风险的区分指标,而双能X线吸收法测得的瘦体重指标不是良好的区分指标。
- 基于握力变量的候选定义与死亡、跌倒、活动障碍及工具性日常生活活动障碍风险增加相关。
- 低握力患病率随年龄增长而升高。
关键数值与推荐
- 活动障碍定义为步行速度<0.8 m/s。
- 握力或握力除以体重指数被确定为活动障碍风险的区分指标,瘦体重指标区分能力不佳。
- 基于握力的候选定义与死亡、跌倒、活动障碍及工具性日常生活活动障碍风险增加相关。
临床怎么用
- 临床评估肌少症风险时可优先关注握力或握力除以体重指数,而非仅依赖瘦体重指标。
- 对握力降低者应关注活动障碍、跌倒、死亡及工具性日常生活活动障碍风险。
- 建议参考国际专家小组基于SDOC分析及文献综合制定的肌少症定义立场声明。
局限性
- 缺乏肌少症诊断共识限制了诊断能力并阻碍药物研发。
- 尚需建立考虑肌少症组分及年龄、性别、种族和共病的预测风险模型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lack of consensus on how to diagnose sarcopenia has limited the ability to diagnose this condition and hindered drug development. The Sarcopenia Definitions and Outcomes Consortium (SDOC) was formed to develop evidence-based diagnostic cut points for lean mass and/or muscle strength that identify people at increased risk of mobility disability. We describe here the proceedings of a meeting of SDOC and other experts to discuss strategic considerations in the development of evidence-based sarcopenia definition. METHODS: Presentations and panel discussions reviewed the usefulness of sarcopenia as a biomarker, the analytical approach used by SDOC to establish cut points, and preliminary findings, and provided strategic direction to develop an evidence-based definition of sarcopenia. RESULTS: The SDOC assembled data from eight epidemiological cohorts consisting of 18,831 participants, clinical populations from 10 randomized trials and observational studies, and 2 nationally representative cohorts. In preliminary assessments, grip strength or grip strength divided by body mass index was identified as discriminators of risk for mobility disability (walking speed <0.8 m/s), whereas dual-energy X-ray absorptiometry-derived lean mass measures were not good discriminators of mobility disability. Candidate definitions based on grip strength variables were associated with increased risk of mortality, falls, mobility disability, and instrumental activities of daily living disability. The prevalence of low grip strength increased with age. The attendees recommended the establishment of an International Expert Panel to review a series of position statements on sarcopenia definition that are informed by the findings of the SDOC analyses and synthesis of literature. CONCLUSIONS: International consensus on an evidence-based definition of sarcopenia is needed. Grip strength-absolute or adjusted for body mass index-is an important discriminator of mobility disability and other endpoints. Additional research is needed to develop a predictive risk model that takes into account sarcopenia components as well as age, sex, race, and comorbidities.
引用
- Cawthon PM, Travison TG, Manini TM, et al. Establishing the Link Between Lean Mass and Grip Strength Cut Points With Mobility Disability and Other Health Outcomes: Proceedings of the Sarcopenia Definition and Outcomes Consortium Conference. J Gerontol A Biol Sci Med Sci. 2020. PMID: 30869772. doi:10.1093/gerona/glz081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。